Shopping Cart
- Remove All
- Your shopping cart is currently empty
Avdoralimab (IPH 5401) is a humanized monoclonal antibody targeting Complement C5a receptor 1 (C5aR1), used in research on bullous pemphigoid and chronic urticaria.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $263 | In Stock | |
5 mg | $795 | In Stock | |
10 mg | $1,260 | In Stock | |
25 mg | $1,870 | In Stock | |
50 mg | $2,520 | In Stock |
Description | Avdoralimab (IPH 5401) is a humanized monoclonal antibody targeting Complement C5a receptor 1 (C5aR1), used in research on bullous pemphigoid and chronic urticaria. |
In vitro | Avdoralimab is a whole-human IgG κb monoclonal antibody that targets the complement C5a receptor 1 (C5aR1), preventing it from binding to C5a. Improving the role of complement cascade in tumor biology by reducing the migration and activation of neutrophils and myeloid suppressor cells to the tumor microenvironment, and enhancing the antitumor activity of effector cells such as T cells and natural killer cells. [1] |
In vivo | Avdoralimab blocked C5A-mediated recruitment and activation of human bone marrow cells and inhibited acute lung injury in human C5aR1 knockin mice. [2] |
Alias | IPH5401, IPH 5401, Anti-C5aR1 mAb |
Cas No. | 2226393-85-5 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.